Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 4
2008 1
2009 2
2010 1
2011 1
2012 5
2013 4
2014 4
2015 4
2016 3
2017 1
2018 2
2019 1
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Results by year
Filters applied: . Clear all
Page 1
A nanoparticle-based approach to improve the outcome of cancer active immunotherapy with lipopolysaccharides.
Shetab Boushehri MA, Abdel-Mottaleb MMA, Béduneau A, Pellequer Y, Lamprecht A. Shetab Boushehri MA, et al. Among authors: beduneau a. Drug Deliv. 2018 Nov;25(1):1414-1425. doi: 10.1080/10717544.2018.1469684. Drug Deliv. 2018. PMID: 29902933 Free PMC article.
Interspecies differences in the cytochrome P450 activity of hepatocytes exposed to PLGA and silica nanoparticles: an in vitro and in vivo investigation.
Cornu R , Rougier N , Pellequer Y , Lamprecht A , Hamon P , Li R , Beduneau A , Martin H . Cornu R , et al. Among authors: beduneau a. Nanoscale. 2018 Mar 15;10(11):5171-5181. doi: 10.1039/c8nr00226f. Nanoscale. 2018. PMID: 29492498
Nanoparticle targeting to inflamed tissues of the gastrointestinal tract.
Moulari B, Beduneau A, Pellequer Y, Lamprecht A. Moulari B, et al. Among authors: beduneau a. Curr Drug Deliv. 2013 Feb;10(1):9-17. doi: 10.2174/1567201811310010004. Curr Drug Deliv. 2013. PMID: 22998041 Review.
Delivery of P-glycoprotein substrates using chemosensitizers and nanotechnology for selective and efficient therapeutic outcomes.
Nieto Montesinos R, Béduneau A, Pellequer Y, Lamprecht A. Nieto Montesinos R, et al. Among authors: beduneau a. J Control Release. 2012 Jul 10;161(1):50-61. doi: 10.1016/j.jconrel.2012.04.034. Epub 2012 Apr 27. J Control Release. 2012. PMID: 22562066 Review.
Active targeting of brain tumors using nanocarriers.
Béduneau A, Saulnier P, Benoit JP. Béduneau A, et al. Biomaterials. 2007 Nov;28(33):4947-67. doi: 10.1016/j.biomaterials.2007.06.011. Epub 2007 Aug 22. Biomaterials. 2007. PMID: 17716726 Review.
Size dependent skin penetration of nanoparticles in murine and porcine dermatitis models.
Try C, Moulari B, Béduneau A, Fantini O, Pin D, Pellequer Y, Lamprecht A. Try C, et al. Among authors: beduneau a. Eur J Pharm Biopharm. 2016 Mar;100:101-8. doi: 10.1016/j.ejpb.2016.01.002. Epub 2016 Jan 12. Eur J Pharm Biopharm. 2016. PMID: 26792104
Nanoparticle-based delivery enhances anti-inflammatory effect of low molecular weight heparin in experimental ulcerative colitis.
Yazeji T, Moulari B, Beduneau A, Stein V, Dietrich D, Pellequer Y, Lamprecht A. Yazeji T, et al. Among authors: beduneau a. Drug Deliv. 2017 Nov;24(1):811-817. doi: 10.1080/10717544.2017.1324530. Drug Deliv. 2017. PMID: 28509629
Stability of fluorescent labels in PLGA polymeric nanoparticles: Quantum dots versus organic dyes.
Abdel-Mottaleb MM, Beduneau A, Pellequer Y, Lamprecht A. Abdel-Mottaleb MM, et al. Among authors: beduneau a. Int J Pharm. 2015 Oct 15;494(1):471-8. doi: 10.1016/j.ijpharm.2015.08.050. Epub 2015 Aug 22. Int J Pharm. 2015. PMID: 26307264
Biorelevant media resistant co-culture model mimicking permeability of human intestine.
Antoine D, Pellequer Y, Tempesta C, Lorscheidt S, Kettel B, Tamaddon L, Jannin V, Demarne F, Lamprecht A, Béduneau A. Antoine D, et al. Among authors: beduneau a. Int J Pharm. 2015 Mar 15;481(1-2):27-36. doi: 10.1016/j.ijpharm.2015.01.028. Epub 2015 Jan 16. Int J Pharm. 2015. PMID: 25601199
In-vitro investigation regarding the effects of Gelucire® 44/14 and Labrasol® ALF on the secretory intestinal transport of P-gp substrates.
Dubray O, Jannin V, Demarne F, Pellequer Y, Lamprecht A, Béduneau A. Dubray O, et al. Among authors: beduneau a. Int J Pharm. 2016 Dec 30;515(1-2):293-299. doi: 10.1016/j.ijpharm.2016.10.012. Epub 2016 Oct 6. Int J Pharm. 2016. PMID: 27720954
36 results
Jump to page
Feedback